10.20.2018 Issue 144

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Associate Director Real World Evidence (RWE) and Epidemiology

The GHEOR RWE and Epidemiology Associate Director is responsible for leading development, coordination, and execution of epidemiology research program for the assigned brands at various stages of development.

Research Data Assistant or Research Data Coordinator-PS8373

Research Associate III- Patient-Centered Research- Hammersmith

Healthcare Software Product Manager

Health Economist

Lead Health Economist

Associate Director Health Economics

Associate Director/ Director, Medical Affairs- HEOR

Watson Health - Outcomes Research Leader (HEOR)

Senior Research Analyst - HEOR


Trump Signs Bills Banning Gag Clauses

A Look at the Evolving Health Market in the EU

Partnership of Hospitals Targets High Drug Prices

Researcher Reflects on 6 Years in Science

AJMC Set to Host Institute for Value-Based Medicine Meeting

Merck CEO Criticizes Middlemen in Supply Chain

Report: Staffing Shortages Trouble Managed Care Payers, State Medicaid Agencies

Visante Rolls Out Thought Leadership Series

Industry Spotlight


Conferences Webinars
MAPS EMEA 2018 Meeting
    October 21-23, Berlin, Germany

Life Sciences Value-Based Contracting
    October 22-23, Alexandria, Virginia

Value-Based Network and Contract Management
    October 22-23, Alexandria, Virginia

ACO Strategy
    October 22-23, Alexandria, Virginia

Extrapolation in Survival Analysis: What? Why? How? Where Next?
    October 22

Drug Pricing Policy: What's on the Horizon?
    October 23

3-Hour Virtual Seminar on MACRA and MIPS - HIPAA Rules for Text Messaging and Email
    October 23

How to Use the Immunization Delivery Cost Catalogue
    October 30


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Health Care USA: A Cancer on the American Dream

The Utility of ICER Reports for Private Payer Drug Coverage Decision-Making: Cost-Effectiveness Assessments

Advancing Biosimilar Sustainability in Europe

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment


Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON    Truven